Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Diabetes Mellitus
Glucose metabolism
• Normal level: 3.5–8.0 mmol/L (63–144 mg/dL)
• Liver absorbs/stores glucose in the postabsorptive stat...
Cause
Type 1 diabetes mellitus:
• due to an autoimmune destruction of the pancreatic β
cells.
• occurs in genetically susc...
Cause
Type 2 DM
• genetic causes of type 2 DM include:
>mutations of the insulin receptor
> structural alterations of the ...
Clinical features
Acute presentation:
• Young pt: 2– 6week hx: thirst, polyuria and wt loss
• Polyuria is due to osmotic d...
Diagnosis
if any one of the following is present:
• Casual plasma glucose ≥11.1 mmol/l
• Fasting plasma glucose ≥7.0 mmol/...
Treatment
Biguanide
• Metformin is a biguanide
• it reduces glucose production by the liver and
sensitizes target tissues ...
• Metformin: can be used in combination tx
when single agent has failed to control DM
Side-effects:
• anorexia and diarrho...
Sulphonylureas: promote insulin secretion.
• Glibenclamide is best avoided in elderly people
and in those with renal failu...
Acarbose: inhibits intestinal α-glucosidases and
impairs carbohydrate digestion and slows
glucose absorption.
• Postprandi...
• Weight loss is associated with improved diabetic
control and even remission of diabetes.
• Orlistat is an intestinal lip...
main types of insulin:
1. Short-acting (soluble) insulins:
• start working within 30–60 minutes andlast for 4–6 hours.
• T...
3. Longer-acting insulins.
• Insulins premixed with retarding agents (either
protamine or zinc) precipitate crystals of va...
• Thank you google…
• Harrisons
• WHO guideline
http://crisbertcualteros.page.tl
Diabetes Mellitus
Diabetes Mellitus
Diabetes Mellitus
Diabetes Mellitus
Upcoming SlideShare
Loading in …5
×

Diabetes Mellitus

1,298 views

Published on

Diabetes Mellitus Management

Published in: Health & Medicine
  • This simple 7 second daily ritual was tested with a group of volunteers. In total 62 people, all suffering from varying levels of obesity. After ninety days the results were more incredible than any of them could have ever imagined… On average they lost 54 pounds of fat... They experienced increased energy… Better mood… Several of them could even see their abs for the first time ever… This simple 7 second ritual had actually worked on everyone! Regardless of how much they had to lose… Their metabolism… Their genetics… or their age. Click Here To Learn More ➜➜➜ https://bit.ly/2XYSZo6
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • 7 Second Daily Ritual Melts Stubborn Fat While You Sleep ☺☺☺ http://tinyurl.com/y33eq8tt
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Why Do We Crave Sugary Food? ☀☀☀ https://t.cn/A6wnCpvk
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Can You Spare 1 Minute Per Day? ●●● https://url.cn/5ODOLl4
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • NO NO NO... ➤➤ https://url.cn/5ODOLl4
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here

Diabetes Mellitus

  1. 1. Diabetes Mellitus
  2. 2. Glucose metabolism • Normal level: 3.5–8.0 mmol/L (63–144 mg/dL) • Liver absorbs/stores glucose in the postabsorptive state and releases it into the circulation between meals to match the rate of glucose utilization by peripheral tissues. • Liver combines 3-carbon molecules derived from breakdown of fat, muscle glycogen (lactate) and protein into the 6-carbon glucose molecule by the process of gluconeogenesis. • Insulin is involved in storage of glycogen in liver and muscle, and triglyceride in fat. • During meal: insulin is released from pancreas into the portal vein and facilitates glucose uptake by fat and muscle and suppresses glucose production by the liver. • Fasting state: insulin are low and modulates glucose production from the liver • Counter-regulatory hormones: glucagon, adrenaline, cortisol and GH: opposes insulin and cause production of glucose from the liver and less utilization of glucose in fat and muscle for a given plasma level of insulin.
  3. 3. Cause Type 1 diabetes mellitus: • due to an autoimmune destruction of the pancreatic β cells. • occurs in genetically susceptible individuals and is triggered by environmental antigens • Autoantibodies against insulin and islet cell antigens (e.g. glutamic acid decarboxylase) predate the onset of clinical disease by several years. • It is an association with other organ-specific autoimmune diseases (autoimmune thyroid disease, Addison’s disease and pernicious anaemia)
  4. 4. Cause Type 2 DM • genetic causes of type 2 DM include: >mutations of the insulin receptor > structural alterations of the insulin molecule • Environmental factors: central obesity: trigger DM in susceptible individuals • β-cell mass is reduced to 50% at time of DX • Hyperglycemia: result of reduced insulin secretion and peripheral insulin resistance
  5. 5. Clinical features Acute presentation: • Young pt: 2– 6week hx: thirst, polyuria and wt loss • Polyuria is due to osmotic diuresis, blood glucose exceed renal tubular reabsorptive capacity • Fluid and electrolyte losses stimulate thirst. • Wt loss is due to fluid depletion and breakdown of fat and muscle secondary to insulin deficiency. • Ketoacidosis: if early sx are not recognized and treated. Subacute presentation: • Older patients may present with the same symptoms, although less marked and extending over several months. • may also complain of lack of energy, visual problems and pruritus vulvae or balanitis due to Candida infection.
  6. 6. Diagnosis if any one of the following is present: • Casual plasma glucose ≥11.1 mmol/l • Fasting plasma glucose ≥7.0 mmol/l • 2-hour postprandial plasma glucose ≥11.1 mmol/l
  7. 7. Treatment Biguanide • Metformin is a biguanide • it reduces glucose production by the liver and sensitizes target tissues to insulin. • It is the first line treatment in patients who have not achieved optimal glucose control with diet alone, in overweight patients • It reduces cardiovascular risk in diabetics.
  8. 8. • Metformin: can be used in combination tx when single agent has failed to control DM Side-effects: • anorexia and diarrhoea • Lactic acidosis in pts with severe heart failure, liver disease or renal disease (serum creatinine > 150 μmol/L), in whom its use is contraindicated.
  9. 9. Sulphonylureas: promote insulin secretion. • Glibenclamide is best avoided in elderly people and in those with renal failure because of its relatively long duration of action (12–20 hours) and renal excretion. • Tolbutamide, which is shorter acting and metabolized by the liver, is a better choice in older pts • The most common side-effect of sulphonylureas is hypoglycaemia, which may be prolonged. • Meglitinides, e.g. repaglinide and nateglinide, are also insulin secretagogues. • They have a rapid onset of action and short duration of action and are administered shortly before each main meal.
  10. 10. Acarbose: inhibits intestinal α-glucosidases and impairs carbohydrate digestion and slows glucose absorption. • Postprandial glucose peaks are reduced. • Gastrointestinal side-effects, e.g. flatulence, bloating and diarrhoea, are common and limit the dose and acceptability of this treatment.
  11. 11. • Weight loss is associated with improved diabetic control and even remission of diabetes. • Orlistat is an intestinal lipase inhibitor and reduces the absorption of fat from the diet. • It promotes weight loss in patients under careful dietary supervision on a low fat diet. • Gastric banding and gastric bypass surgery should be offered to those with marked obesity unresponsive to 6 months intensive attempts at dieting and graded exercise.
  12. 12. main types of insulin: 1. Short-acting (soluble) insulins: • start working within 30–60 minutes andlast for 4–6 hours. • They are given 15–30 minutes before meals in patients on multiple dose regimens 2. Short-acting insulin analogues • human insulin analogues (insulin aspart, insulin lispro, insulin glulisine) have a faster onset and shorter duration of action than soluble insulin but overall do not improve diabetic control. • They have a reduced carry-over effect compared to soluble insulin and are used with the evening meal in patients who are prone to nocturnal hypoglycaemia.
  13. 13. 3. Longer-acting insulins. • Insulins premixed with retarding agents (either protamine or zinc) precipitate crystals of varying size according to the conditions employed • These insulins are intermediate (12–24 hours) or long acting (more than 24 hours). • The protamine insulins are also known as isophane or NPH insulins • zinc insulins as lente insulins • Insulin glargine is a structurally modified insulin that precipitates in tissues and is then slowly released from the injection site.
  14. 14. • Thank you google… • Harrisons • WHO guideline http://crisbertcualteros.page.tl

×